Approval · Notice of Compliance 23779 · 2020
DANTRIUM CAPSULES: Notice of Compliance 23779
Issued June 12, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23779
- Date
- June 12, 2020
- Company
- Endo Par Innovation Company, LlcChestnut Ridge, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an alternate drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DANTRIUM CAPSULES | Not yet assigned | — |
Medicinal ingredients
- DANTROLENE SODIUM 25 MG per CAP